SEARCH

SEARCH BY CITATION

References

  • BENOWITZ, N.L. & JONES, R.T. (1975). Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin. Pharmacol. Ther., 18, 287297.
  • BENOWITZ, N.L., ROSENBERG, J., ROGERS, W., BACHMAN, J. & JONES, R.T. (1979). Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin. Pharmacol. Ther., 25, 440446.
  • BIANCHI, A.L., DENAVIT-SAUBIE, M. & CHAMPAGNAT, J. (1995). Central control of breathing in mammals: neuronal circuitry, membrane properties, and neurotransmitters. Physiol. Rev., 75, 245.
  • BREIVOGEL, C.S., GRIFFIN, G., DI MARZO, V. & MARTIN, B.R. (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol., 60, 155163.
  • BREIVOGEL, C.S., SIM, L.J. & CHILDERS, S.R. (1997). Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther., 282, 16321642.
  • CHITRAVANSHI, V.C. & SAPRU, H.N. (1999). Phrenic nerve responses to chemical stimulation of the subregions of ventral medullary respiratory neuronal group in the rat. Brain Res., 821, 443460.
  • COSENZA, M., GIFFORD, A.N., GATLEY, J., PYATT, B., LIU, Q., MAKRIYANNIS, A. & VOLKOW, N.D. (2000). Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281. Synapse, 38, 477482.
  • DOHERTY, P.A., McCARTHY, L.E. & BORISON, H.L. (1983). Respiratory and cardiovascular depressant effects of nabilone, N-methyllevonantradol and delta-9-tetrahydrocannabinol in anaesthetised cats. J. Pharmacol. Exp. Ther., 227, 508516.
  • ESTRADA, U., BRASE, D.A., MARTIN, B.R. & DEWEY, W.L. (1987). Cardiovascular effects of delta-9- and delta-9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sci., 41, 7987.
  • EZURE, K. (1990). Synaptic connections between medullary respiratory neurons and considerations on the genesis of respiratory rhythm. Prog. Neurobiol., 35, 429450.
  • GARDINER, S.M., MARCH, J.E., KEMP, P.A. & BENNETT, T. (2001). Regional haemodynamic responses to the cannabinoid agonist, WIN55,212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats. Br. J. Pharmacol., 133, 445453.
  • GARDINER, S.M., MARCH, J.E., KEMP, P.A. & BENNETT, T. (2002). Influence of the CB1 receptor antagonist, AM251, on the regional haemodynamic effects of WIN55,212-2 or HU-210 in conscious rats. Br. J. Pharmacol., 136, 581587.
  • GATLEY, S.J., LAN, R., VOLKOW, N.D., PAPPAS, N., KING, P., WONG, C.T., GIFFORD, A.N., PYATT, B., DEWEY, S.L. & MAKRIYANNIS, A. (1998). Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoids CB1 receptors in vivo. J. Neurochem., 70, 417423.
  • GERAGHTY, D.P. & MAZZONE, S.B. (2002). Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferotoxin with non-pungent agents and anandamide. Br. J. Pharmacol., 137, 919927.
  • GIFFORD, A.N., BRUNEUS, M., GATLEY, S.J., LAN, R.X., MAKRIYANNIS, A. & VOLKOW, N.D. (1999). Large receptor reserve for cannabinoid actions in the central nervous system. J. Pharmacol. Exp. Ther., 288, 478483.
  • GRAHAM, J.D. & LI, D.M. (1973). Cardiovascular and respiratory effects of cannabis in cat and rat. Br. J. Pharmacol., 49, 110.
  • HERKENHAM, M., LYNN, A.B., JOHNSON, M.R., MELVIN, L.S., DE COSTA, B.R. & RICE, K.C. (1991). Characterisation and localisation of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563583.
  • HILLARD, C.J. (2000). Endocannabinoids and vascular function. J. Pharmacol. Exp. Ther., 294, 2732.
  • HOWLETT, A.C., BARTH, F., BONNER, T.I., CABRAL, G., CASELLAS, P., DEVANE, W.A., FELDER, C.C., HERKENHAM, M., MACKIE, K., MARTIN, B.R., MECHOULAM, R. & PERTWEE, R.G. (2002). International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 54, 161202.
  • ISHAC, E.J.N., JIANG, L., LAKE, K.D., VARGA, K., ABOOD, M.E. & KUNOS, G. (1996). Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 20232028.
  • JANDHYALA, B.S. & HAMED, A.T. (1978). Pulmonary and systemic hemodynamic effects of delta9-tetrahydrocannabinol in conscious and morphine-chloralose-anaesthetised dogs: anesthetic influence on drug action. Eur. J. Pharmacol., 53, 6368.
  • KANJHAN, R., LIPSKI, J., KRUSZEWSKA, B. & RONG, W. (1995). A comparative study of pre-sympathetic and Botzinger neurons in the rostral ventrolateral medulla (RVLM) of the rat. Brain Res., 699, 1932.
  • KAWASAKI, H., WATANABE, S., OISHI, R. & UEKI, S. (1980). Effects of delta-9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in rats. Jpn. J. Pharmacol., 30, 493502.
  • LAKE, K.D., COMPTON, D.R., VARGA, K., MARTIN, B.R. & KUNOS, G. (1997a). Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors. J. Pharmacol. Exp. Ther., 281, 10301037.
  • LAKE, K.D., MARTIN, B.R., KUNOS, G. & VARGA, K. (1997b). Cardiovascular effects of anandamide in anesthetised and conscious normotensive and hypertensive rats. Hypertension, 29, 12041210.
  • LEDENT, C., VALVERDE, O., COSSU, G., PETITET, F., AUBERT, J.F., BESLOT, F., BOHME, G.A., IMPERATO, A., PEDRAZZINI, T., ROQUES, B.P., VASSART, G., FRATTA, W. & PARMENTIER, M. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1receptor knockout mice. Science, 283, 401404.
  • LI, Q., GOODCHILD, A.M. & PILOWSKY, P.M. (2003). The effect of haemorrhage on neurotransmitter-related genes in rat ventrolateral medulla: a quantitative real-time-RT–PCR study. Mol. Brain Res., 114, 4654.
  • MAILLEUX, P., PARMENTIER, M. & VANDERHAGEN, J.J. (1992). Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides. Neurosci. Lett., 143, 200204.
  • MARTIN, W.J., TSOU, K. & WALKER, J.M. (1998). Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci. Lett., 242, 3336.
  • MATSUDA, L.A., BONNER, T.I. & LOLAIT, S.J. (1993). Localisation of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol., 327, 535550.
  • MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561564.
  • MILLIGAN, G. & BOND, R.A. (1997). Inverse agonism and the regulation of receptor number. Trends Pharmacol. Sci., 18, 468474.
  • MIYAWAKI, T., GOODCHILD, A.K. & PILOWSKY, P.M. (2003). Maintenance of sympathetic tone by a nickel chloride sensitive mechanism in the rostral ventrolateral medulla of the adult rat. Neuroscience, 116, 455464.
  • MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterisation of a peripheral receptor for cannabinoids. Nature, 365, 6165.
  • NIEDERHOFFER, N., SCHMID, K. & SZABO, B. (2001). Analysis of the cardiovascular depressive effects of cannabinoids in anaesthetised rats (abstract). Naunyn-Schmiedeberg's Arch. Pharmacol., 363, R27.
  • NIEDERHOFFER, N. & SZABO, B. (1999). Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Br. J. Pharmacol., 126, 457466.
  • NIEDERHOFFER, N. & SZABO, B. (2000). Cannabinoids cause central sympathoexcitation and bradycardia in rabbits. J. Pharmacol. Exp. Ther., 294, 707713.
  • ONAIVI, E.S., LEONARD, C.M., ISHIGURO, H., ZANG, P.W., LIN, Z., AKINSHOLA, B.E. & UHL, G.R. (2002). Endocannabinoid and receptor genetics. Prog. Neurobiol., 567, 138.
  • PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates, 2nd edn. London: Academic Press.
  • PILOWSKY, P.M. (1995). Good vibrations? Respiratory rhythms in the central control of blood pressure. Clin. Exp. Pharmacol. Physiol., 22, 594604.
  • PILOWSKY, P.M. & GOODCHILD, A.K. (2002). Baroreceptor reflex pathways and neurotransmitters: 10 years on. J. Hypertens., 20, 16751688.
  • PILOWSKY, P.M., JIANG, C. & LIPSKI, J. (1990). An intracellular study of respiratory neurons in the rostral ventrolateral medulla of the rat and their relationship to catecholamine-containing neurons. J. Comp. Neurol., 301, 604617.
  • RADEMACHER, D.J., PATEL, S., HOPP, F.A., DEAN, C., HILLARD, C.J. & SEAGARD, J.L. (2003). Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs. Am. J. Physiol. Heart Circ. Physiol., 284, H1570H1576.
  • SALIO, C., FISCHER, J., FOSCA FRANZONI, M., MACKIE, K., KANEKO, T. & CONRATH, M. (2001). CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport, 12, 36893692.
  • SCHREIHOFER, A.M., STORNETTA, R.L. & GUYENET, P.G. (1999). Evidence for glycinergic respiratory neurons: Botzinger neurons express mRNA for glycinergic transporter 2. J. Comp. Neurol., 407, 583597.
  • SMITH, P.J.W. & McQUEEN, D.S. (2001). Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetised rat. Br. J. Pharmacol., 134, 655663.
  • SUN, Q.-J., GOODCHILD, A.K., CHALMERS, J. & PILOWSKY, P.M. (1998). The pre-Botzinger complex and phase-spanning neurons in the adult rat. Brain Res., 809, 204213.
  • SZABO, B., PFITZER, T. & NIEDERHOFFER, N. (2002). Central respiratory effects of cannabinoids in rats. Conference Proceedings, 12th Annual Symposium on the Cannabinoids, California, U.S.A.
  • TSOU, K., BROWN, S., SANUDO-PENA, M.C., MACKIE, K. & WALKER, J.M. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393411.
  • VAUGHAN, C.W., CONNOR, M., BAGLEY, E. & CHRISTIE, M.J. (2000). Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal grey neurons in vitro. Mol. Pharmacol., 57, 288295.
  • VAUGHAN, C.W., McGREGOR, I.S. & CHRISTIE, M.J. (1999). Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventrolateral medulla neurons in vitro. Br. J. Pharmacol., 127, 935940.
  • VOLLMER, R.R., CAVERO, I., ERTEL, R.J., SOLOMON, T. & BUCKLEY, J.P. (1974). Role of the central autonomic nervous system in the hypotension and bradycardia induced by (−)-delta-9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther., 26, 186192.